DANIEL BUTLER: Open Payments
NPI 1619958097 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,158 in 65 payments from 26 companies in 2025. Trend: 2023 $941 · 2024 $1,395 · 2025 $1,158
Food & beverage: $1,158
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $215 |
| Novo Nordisk Inc | 18 | $188 |
| Lilly USA, LLC | 9 | $130 |
| Lundbeck LLC | 3 | $53 |
| ABBVIE INC. | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Amgen Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
Products named: BREZTRI, JARDIANCE, REXULTI, Ozempic, MOUNJARO, Wegovy, UBRELVY, Qelbree.
Industry payments across KY — which companies pay providers there.
